Laake K, Kjeldaas L, Borchgrevink C F
Acta Med Scand. 1984;215(1):81-3.
In the first year after registration, 103 reports on suspected adverse reaction to piroxicam (Feldene) were submitted to the Norwegian Adverse Drug Reaction Committee. Eighty-three reactions were classified as probable side-effects, and 73 of these were related to the upper gastrointestinal tract. Peptic ulcer and upper gastrointestinal haemorrhages predominated. Two deaths were classified as probably due to piroxicam. There were 8 life-threatening reactions, all due to haemorrhages. No severe cutaneous reactions were reported. A significant fraction of the gastrointestinal reactions occurred in patients with a previous history of peptic ulcer disease. Nearly every fourth patient with proven ulcer or haematemesis/melaena had simultaneously been taking other drugs with the propensity of causing gastrointestinal haemorrhage. The gastrointestinal adverse reactions to piroxicam can probably be reduced by a more accurate selection of patients.
在注册后的第一年,103份关于吡罗昔康(费啶)疑似不良反应的报告提交给了挪威药物不良反应委员会。83例反应被归类为可能的副作用,其中73例与上消化道有关。消化性溃疡和上消化道出血占主导。2例死亡被归类为可能由吡罗昔康所致。有8例危及生命的反应,均因出血。未报告严重的皮肤反应。相当一部分胃肠道反应发生在既往有消化性溃疡病史的患者中。几乎每四分之一确诊为溃疡或呕血/黑便的患者同时还在服用其他有导致胃肠道出血倾向的药物。通过更精确地选择患者,吡罗昔康的胃肠道不良反应可能会减少。